SitesBLAST
Comparing WP_009130737.1 NCBI__GCF_000315485.1:WP_009130737.1 to proteins with known functional sites using BLASTp with E ≤ 0.001.
Or try Sites on a Tree, PaperBLAST, Conserved Domains, or compare to all protein structures
Found 20 (the maximum) hits to proteins with known functional sites (download)
P07821 Iron(3+)-hydroxamate import ATP-binding protein FhuC; Ferric hydroxamate uptake protein C; Ferrichrome transport ATP-binding protein FhuC; Iron(III)-hydroxamate import ATP-binding protein FhuC; EC 7.2.2.16 from Escherichia coli (strain K12) (see 2 papers)
39% identity, 57% coverage: 28:216/333 of query aligns to 30:218/265 of P07821
- K50 (= K48) mutation to Q: Lack of activity.
- D172 (= D170) mutation to E: Lack of activity.
- E173 (= E171) mutation to A: Lack of activity.
P75957 Lipoprotein-releasing system ATP-binding protein LolD; EC 7.6.2.- from Escherichia coli (strain K12) (see paper)
33% identity, 65% coverage: 1:218/333 of query aligns to 1:218/233 of P75957
- G42 (= G42) mutation to D: Loss of lipoprotein release when overexpressed.
7z15I E. Coli c-p lyase bound to a phnk/phnl dual abc dimer and adp + pi (see paper)
32% identity, 70% coverage: 3:234/333 of query aligns to 1:232/253 of 7z15I
- binding adenosine-5'-diphosphate: Y13 (= Y15), K17 (= K19), G18 (≠ Q20), S38 (≠ N44), G39 (= G45), G41 (= G47), K42 (= K48), T43 (≠ S49), T44 (= T50), R136 (≠ K138), T143 (≠ E145), S145 (= S147), M148 (≠ E150)
- binding magnesium ion: T43 (≠ S49), Q88 (vs. gap)
7z18I E. Coli c-p lyase bound to a phnk abc dimer and atp (see paper)
32% identity, 70% coverage: 3:234/333 of query aligns to 1:232/250 of 7z18I
- binding adenosine-5'-triphosphate: Y13 (= Y15), S38 (≠ N44), G39 (= G45), S40 (≠ T46), G41 (= G47), K42 (= K48), T43 (≠ S49), T44 (= T50), Q88 (vs. gap), R136 (≠ K138), T143 (≠ E145), S145 (= S147), G147 (= G149), M148 (≠ E150), H202 (= H204)
- binding magnesium ion: T43 (≠ S49), Q88 (vs. gap)
7z16I E. Coli c-p lyase bound to phnk/phnl dual abc dimer with amppnp and phnk e171q mutation (see paper)
32% identity, 70% coverage: 3:234/333 of query aligns to 1:232/250 of 7z16I
- binding phosphoaminophosphonic acid-adenylate ester: Y13 (= Y15), K17 (= K19), S38 (≠ N44), G39 (= G45), S40 (≠ T46), G41 (= G47), K42 (= K48), T43 (≠ S49), T44 (= T50), R136 (≠ K138), T143 (≠ E145), S145 (= S147), G147 (= G149), M148 (≠ E150), H202 (= H204)
7v8iD Lolcd(e171q)e with bound amppnp in nanodiscs (see paper)
32% identity, 65% coverage: 2:218/333 of query aligns to 1:217/229 of 7v8iD
- binding phosphoaminophosphonic acid-adenylate ester: V23 (= V24), S43 (≠ N44), G44 (= G45), G46 (= G47), K47 (= K48), S48 (= S49), T49 (= T50), Q93 (≠ T90), R137 (≠ K138), H140 (≠ S141), E144 (= E145), S146 (= S147), G148 (= G149), E149 (= E150), H203 (= H204)
- binding magnesium ion: S48 (= S49), Q93 (≠ T90)
7arlD Lolcde in complex with lipoprotein and adp (see paper)
32% identity, 64% coverage: 5:218/333 of query aligns to 2:215/222 of 7arlD
7mdyC Lolcde nucleotide-bound
32% identity, 64% coverage: 5:218/333 of query aligns to 2:215/226 of 7mdyC
- binding adp orthovanadate: Y12 (= Y15), G42 (= G45), S43 (≠ T46), G44 (= G47), K45 (= K48), S46 (= S49), T47 (= T50), Q91 (≠ T90), H138 (≠ S141), E142 (= E145), S144 (= S147), G145 (≠ D148), G146 (= G149), E168 (= E171), N172 (≠ F175), H201 (= H204)
- binding magnesium ion: S46 (= S49), Q91 (≠ T90)
5xu1B Structure of a non-canonical abc transporter from streptococcus pneumoniae r6 (see paper)
33% identity, 62% coverage: 3:209/333 of query aligns to 1:206/226 of 5xu1B
6z67B Ftse structure of streptococcus pneumoniae in complex with amppnp at 2.4 a resolution (see paper)
34% identity, 53% coverage: 28:205/333 of query aligns to 23:198/229 of 6z67B
Sites not aligning to the query:
6z4wA Ftse structure from streptococcus pneumoniae in complex with adp (space group p 1) (see paper)
34% identity, 53% coverage: 28:205/333 of query aligns to 23:198/230 of 6z4wA
Sites not aligning to the query:
A0A0H2ZM82 Cell division ATP-binding protein FtsE from Streptococcus pneumoniae serotype 2 (strain D39 / NCTC 7466) (see paper)
34% identity, 53% coverage: 28:205/333 of query aligns to 23:198/230 of A0A0H2ZM82
- K43 (= K48) mutation to A: Growth cessation and formation of spherical cells with aberrant division planes.
- D164 (= D170) mutation to A: Growth cessation and formation of spherical cells with aberrant division planes.
- E165 (= E171) mutation to A: Growth cessation and formation of spherical cells with aberrant division planes.
8wm7D Cryo-em structure of cyanobacterial nitrate/nitrite transporter nrtbcd in complex with signalling protein pii (see paper)
30% identity, 63% coverage: 24:233/333 of query aligns to 23:225/257 of 8wm7D
Sites not aligning to the query:
O95477 Phospholipid-transporting ATPase ABCA1; ATP-binding cassette sub-family A member 1; ATP-binding cassette transporter 1; ABC-1; ATP-binding cassette 1; Cholesterol efflux regulatory protein; EC 7.6.2.1 from Homo sapiens (Human) (see 35 papers)
31% identity, 71% coverage: 3:239/333 of query aligns to 896:1122/2261 of O95477
- D917 (≠ E26) to Y: in a colorectal cancer sample; somatic mutation
- T929 (= T38) to I: in TGD; moderately decreased protein abundance; highly decreased ATPase activity; highly decreased phospholipid translocase activity; loss protein subcellular localization to the plasma membrane
- N935 (= N44) to S: in TGD; moderately decreased protein abundance; highly decreased ATPase activity; highly decreased phospholipid translocase activity; dbSNP:rs28937313
- K939 (= K48) mutation to M: Inhibits ATPase activity; when associated with M-1952. Decreases translocase activity; when associated with M-1952. Does not affect protein subcellular localization in plasma membrane and endosome; when associated with M-1952.
- S1042 (≠ M155) modified: Phosphoserine; by PKA
- P1065 (≠ V178) natural variant: P -> S
- M1091 (≠ I206) to T: in FHA1; loss of localization to plasma membrane; decreased cholesterol efflux; decreased phospholipid efflux
- C1110 (= C227) modified: S-palmitoyl cysteine; mutation to S: Decreased palmitoylation; when associated with S-3, S-23 and S-1111.
- C1111 (≠ G228) modified: S-palmitoyl cysteine; mutation to S: Decreased palmitoylation; when associated with S-3, S-23 and S-1110.
Sites not aligning to the query:
- 3 modified: S-palmitoyl cysteine; C→S: Mild decrease of palmitoylation. Loss of localization to plasma membrane. Decreased cholesterol efflux. Decreased phospholipid efflux. Decreased palmitoylation; when associated with S-23, S-1110 and S-1111.
- 23 modified: S-palmitoyl cysteine; C→S: Mild decrease of palmitoylation. Loss of localization to plasma membrane. Decreased palmitoylation; when associated with S-3, S-1110 and S-1111.
- 74 I→C: 85-90% reduction in phospholipid and cholesterol efflux but no effect on localization to cell membrane; when associated with C-371.; I→K: 85-90% reduction in phospholipid and cholesterol efflux but no effect on localization to cell membrane; when associated with E-371.
- 75 modified: Disulfide link with 309
- 85 P → L: in FHA1; Alabama; dbSNP:rs145183203
- 98 modified: carbohydrate, N-linked (GlcNAc...) asparagine
- 100 S→C: Highly decreased protein abundance. Highly decreased ATPase activity. Highly decreased phospholipid translocase activity.
- 210 E → D: in a colorectal cancer sample; somatic mutation
- 219 R → K: in dbSNP:rs2230806
- 230 R → C: in dbSNP:rs9282541
- 244 modified: carbohydrate, N-linked (GlcNAc...) asparagine
- 248 P → A: in dbSNP:rs142625938
- 255 A → T: in TGD; deficient cellular cholesterol efflux; dbSNP:rs758100110
- 304 V→C: No effect on phospholipid and cholesterol efflux or localization to cell membrane; when associated with C-308.
- 308 V→C: No effect on phospholipid and cholesterol efflux or localization to cell membrane; when associated with C-304.
- 309 modified: Disulfide link with 75
- 364 S → C: in dbSNP:rs775035559
- 371 I→C: No effect on phospholipid and cholesterol efflux or localization to cell membrane. 85-90% reduction in phospholipid and cholesterol efflux but no effect on localization to cell membrane; when associated with C-74 or C-375.; I→E: 85-90% reduction in phospholipid and cholesterol efflux but no effect on localization to cell membrane; when associated with K-74.
- 375 L→C: 85-90% reduction in phospholipid and cholesterol efflux but no effect on localization to cell membrane; when associated with C-371.
- 399 V → A: in dbSNP:rs9282543
- 401 K → Q: in dbSNP:rs138487227
- 496 R → W: in dbSNP:rs147675550
- 568 K→A: 60-65% reduction in phospholipid and cholesterol efflux but no effect on localization to cell membrane.
- 573 Y→F: No effect on phospholipid and cholesterol efflux and on localization to cell membrane.
- 581 D→K: 80-85% reduction in phospholipid and cholesterol efflux but no effect on localization to cell membrane; when associated with K-584 and K-585.
- 583 F→K: 90-95% reduction in phospholipid and cholesterol efflux but no effect on localization to cell membrane; when associated with E-590.
- 584 E→K: 80-85% reduction in phospholipid and cholesterol efflux but no effect on localization to cell membrane; when associated with K-581 and K-585.
- 585 D→K: 80-85% reduction in phospholipid and cholesterol efflux but no effect on localization to cell membrane; when associated with K-581 and K-584.
- 590 W → S: in TGD; moderately decreased protein abundance; highly decreased ATPase activity; highly decreased phospholipid translocase activity; dbSNP:rs137854496; W→E: 90-95% reduction in phospholipid and cholesterol efflux but no effect on localization to cell membrane; when associated with K-583.
- 593 F→L: Moderately decreased protein abundance. Highly decreased ATPase activity. Highly decreased phospholipid translocase activity.
- 638 R → Q: in dbSNP:rs374190304
- 771 V → M: in dbSNP:rs2066718
- 774 T → P: in dbSNP:rs35819696; natural variant: T -> S
- 776 K → N: in dbSNP:rs138880920
- 815 E → G: in dbSNP:rs145582736
- 825 V → I: in dbSNP:rs2066715
- 883 I → M: in dbSNP:rs2066714
- 1172 E → D: in dbSNP:rs33918808
- 1181 S → F: in dbSNP:rs76881554
- 1216 G → V: in dbSNP:rs562403512
- 1341 R → T: in dbSNP:rs147743782
- 1376 S → G: in dbSNP:rs145689805
- 1379 L → F: in TGD; the mutant protein is retained in the endoplasmic reticulum while the wild-type protein is located at the plasma membrane
- 1407 A → T: in a colorectal cancer sample; somatic mutation; dbSNP:rs189206655
- 1463 modified: Disulfide link with 1477
- 1477 modified: Disulfide link with 1463; C → R: in TGD; loss of interaction with APOE; unable to generate APOE-containing high density lipoproteins; moderately decreased protein abundance; moderately decreased ATPase activity; moderately decreased phospholipid translocase activity; dbSNP:rs137854494
- 1512 T→M: Moderately decreased protein abundance. Does not affect ATPase activity. Moderately decreased phospholipid translocase activity.
- 1555 I → T: in dbSNP:rs1997618
- 1587 K → R: in dbSNP:rs2230808
- 1611 N → D: in FHA1; deficient cellular cholesterol efflux
- 1615 R → Q: in dbSNP:rs1251839800
- 1648 L → P: in dbSNP:rs1883024
- 1670 A → T: in dbSNP:rs1203589782
- 1680 R → Q: in dbSNP:rs150125857
- 1704 V → D: in TGD; the mutant protein is retained in the endoplasmic reticulum while the wild-type protein is located at the plasma membrane
- 1731 S → C: in dbSNP:rs760507032
- 1897 R → W: in FHA1; uncertain significance; dbSNP:rs760768125
- 1925 R → Q: in Scott syndrome; shows impaired trafficking of the mutant protein to the plasma membrane; dbSNP:rs142688906
- 1952 K→M: Inhibits ATPase activity; when associated with M-939. Decreases translocase activity; when associated with M-939. Does not affect protein subcellular localization in plasma membrane and endosome; when associated with M-939.
- 2054 modified: Phosphoserine; by PKA
- 2081 R → W: in TGD; highly decreased protein abundance; highly decreased ATPase activity; highly decreased phospholipid translocase activity; loss protein subcellular localization to the plasma membrane; dbSNP:rs137854501
- 2109 A → T: in a colorectal cancer sample; somatic mutation
- 2150 P → L: in FHA1; moderately decreased protein abundance; does not affect ATPase activity; moderately decreased phospholipid translocase activity; dbSNP:rs369098049
- 2163 natural variant: F -> S
- 2168 L → P: in dbSNP:rs2853577
- 2243 D → E: in dbSNP:rs34879708
- 2244 V → I: in dbSNP:rs144588452
8w9mD Cryo-em structure of the cyanobacterial nitrate transporter nrtbcd in complex with atp (see paper)
29% identity, 63% coverage: 24:233/333 of query aligns to 21:223/256 of 8w9mD
- binding adenosine-5'-triphosphate: H40 (≠ A43), S41 (≠ N44), G42 (= G45), G44 (= G47), K45 (= K48), S46 (= S49), T47 (= T50), Q82 (≠ T90), Q135 (≠ E145), S137 (= S147), G139 (= G149), M140 (≠ E150), H194 (= H204)
- binding magnesium ion: S46 (= S49), Q82 (≠ T90)
Sites not aligning to the query:
7tbwA The structure of atp-bound abca1 (see paper)
30% identity, 70% coverage: 6:239/333 of query aligns to 754:977/1928 of 7tbwA
- binding adenosine-5'-triphosphate: Y763 (= Y15), D765 (≠ Q17), K768 (= K22), N790 (= N44), G791 (= G45), G793 (= G47), K794 (= K48), T795 (≠ S49), Q835 (≠ T90), Q887 (≠ E145), S889 (= S147), H944 (= H204)
- binding magnesium ion: Q835 (≠ T90), D912 (= D170), Q913 (≠ E171)
Sites not aligning to the query:
- binding adenosine-5'-triphosphate: 1630, 1633, 1657, 1658, 1660, 1661, 1662, 1663, 1702, 1753, 1755, 1756, 1757, 1779, 1783, 1811
- binding cholesterol: 218, 219, 360, 367
- binding magnesium ion: 1662, 1702
P41233 Phospholipid-transporting ATPase ABCA1; ATP-binding cassette sub-family A member 1; ATP-binding cassette transporter 1; ABC-1; ATP-binding cassette 1; EC 7.6.2.1 from Mus musculus (Mouse) (see paper)
30% identity, 70% coverage: 6:239/333 of query aligns to 899:1122/2261 of P41233
Sites not aligning to the query:
- 489 modified: carbohydrate, N-linked (GlcNAc...) asparagine
8iddA Cryo-em structure of mycobacterium tuberculosis atp bound ftsex/ripc complex in peptidisc (see paper)
34% identity, 54% coverage: 26:205/333 of query aligns to 21:198/225 of 8iddA
Sites not aligning to the query:
8igqA Cryo-em structure of mycobacterium tuberculosis adp bound ftsex/ripc complex in peptidisc (see paper)
34% identity, 54% coverage: 26:205/333 of query aligns to 21:198/227 of 8igqA
Sites not aligning to the query:
P68187 Maltose/maltodextrin import ATP-binding protein MalK; EC 7.5.2.1 from Escherichia coli (strain K12) (see 5 papers)
29% identity, 62% coverage: 24:228/333 of query aligns to 18:216/371 of P68187
- A85 (≠ T93) mutation to M: Suppressor of EAA loop mutations in MalFG.
- K106 (≠ L118) mutation to C: Suppressor of EAA loop mutations in MalFG.
- V114 (≠ I126) mutation to C: Suppressor of EAA loop mutations in MalFG.
- V117 (≠ A129) mutation to M: Suppressor of EAA loop mutations in MalFG.
- E119 (= E131) mutation to K: Resistant to inhibitory effects of alpha-methylglucoside but retains transport capacity.
- A124 (≠ S136) mutation to T: Resistant to inhibitory effects of alpha-methylglucoside but retains transport capacity.
- G137 (= G149) mutation to A: Loss of maltose transport. Has greater ability to decrease mal gene expression than wild-type MalK.
- D158 (= D170) mutation to N: Loss of maltose transport but retains ability to repress mal genes.
Sites not aligning to the query:
- 228 R→C: Resistant to inhibitory effects of alpha-methylglucoside but retains transport capacity.
- 241 F→I: Resistant to inhibitory effects of alpha-methylglucoside but retains transport capacity.
- 267 W→G: Normal maltose transport but constitutive mal gene expression.
- 278 G→P: Resistant to inhibitory effects of alpha-methylglucoside but retains transport capacity.
- 282 S→L: Resistant to inhibitory effects of alpha-methylglucoside but retains transport capacity.
- 284 G→S: Resistant to inhibitory effects of alpha-methylglucoside but retains transport capacity.
- 302 G→D: Resistant to inhibitory effects of alpha-methylglucoside but retains transport capacity.
- 308 E→Q: Maltose transport is affected but retains ability to interact with MalT.
- 322 S→F: Resistant to inhibitory effects of alpha-methylglucoside but retains transport capacity.
- 340 G→A: Maltose transport is affected but retains ability to interact with MalT.
- 346 G→S: Normal maltose transport but constitutive mal gene expression.
- 355 F→Y: Maltose transport is affected but retains ability to interact with MalT.
Query Sequence
>WP_009130737.1 NCBI__GCF_000315485.1:WP_009130737.1
MEKAVITANNLCIGYRQGKQEKRVHEHLSFQLYPGELTCLLGANGTGKSTLLRTLAASQP
ALSGELLVEDKPLSAYSEKERSRTIGVVLTDKTQAGGLTVYELVALGRQPHTGFFGRLNK
ADHAIIEEALEAVSISHKAQSYTAELSDGERQKVMIAKALVQECPLILLDEPTAFLDVVS
RIEIMTLLHRLAVEQSKAILLSTHDIEQALVLADKLWLLSKENGLQCGVTEDMILSHRMD
GLFSRNDIRFDYAHGVYYPKVDSHRNIIVEASDEVLLHWTTNALNRHGYACCSDSVAETS
SLPRLQVLSAEDFRLHKEKEYKFHSFEQLLANV
Or try a new SitesBLAST search
SitesBLAST's Database
SitesBLAST's database includes
(1) SwissProt
entries with experimentally-supported functional features;
and (2) protein structures with bound ligands, from the
BioLip database.
by Morgan Price,
Arkin group
Lawrence Berkeley National Laboratory